131 related articles for article (PubMed ID: 31702049)
21. Phase I-II study of lenalidomide and alemtuzumab in refractory chronic lymphocytic leukemia (CLL): effects on T cells and immune checkpoints.
Winqvist M; Mozaffari F; Palma M; Eketorp Sylvan S; Hansson L; Mellstedt H; Österborg A; Lundin J
Cancer Immunol Immunother; 2017 Jan; 66(1):91-102. PubMed ID: 27815572
[TBL] [Abstract][Full Text] [Related]
22. Expansion of CD4+ T cells with a cytotoxic phenotype in patients with B-chronic lymphocytic leukaemia (B-CLL).
Porakishvili N; Roschupkina T; Kalber T; Jewell AP; Patterson K; Yong K; Lydyard PM
Clin Exp Immunol; 2001 Oct; 126(1):29-36. PubMed ID: 11678896
[TBL] [Abstract][Full Text] [Related]
23. Human CD8
Machicote A; Belén S; Baz P; Billordo LA; Fainboim L
Front Immunol; 2018; 9():2788. PubMed ID: 30555473
[TBL] [Abstract][Full Text] [Related]
24. T cells from CLL patients exhibit features of T-cell exhaustion but retain capacity for cytokine production.
Riches JC; Davies JK; McClanahan F; Fatah R; Iqbal S; Agrawal S; Ramsay AG; Gribben JG
Blood; 2013 Feb; 121(9):1612-21. PubMed ID: 23247726
[TBL] [Abstract][Full Text] [Related]
25. Patients with B cell chronic lymphocytic leukaemia have an expanded population of CD4 perforin expressing T cells enriched for human cytomegalovirus specificity and an effector-memory phenotype.
Walton JA; Lydyard PM; Nathwani A; Emery V; Akbar A; Glennie MJ; Porakishvili N
Br J Haematol; 2010 Jan; 148(2):274-84. PubMed ID: 19895614
[TBL] [Abstract][Full Text] [Related]
26. Peripheral blood lymphocyte phenotype of ZAP-70⁺ and ZAP-70⁻ patients with B-cell chronic lymphocytic leukaemia.
Rivkina A; Holodnuka-Kholodyuk I; Murovska M; Soloveichika M; Lejniece S
Exp Oncol; 2015 Mar; 37(1):73-6. PubMed ID: 25804237
[TBL] [Abstract][Full Text] [Related]
27. Differential sensitivity of CD4+ and CD8+ T lymphocytes to the killing efficacy of Fas (Apo-1/CD95) ligand+ tumor cells in B chronic lymphocytic leukemia.
Tinhofer I; Marschitz I; Kos M; Henn T; Egle A; Villunger A; Greil R
Blood; 1998 Jun; 91(11):4273-81. PubMed ID: 9596676
[TBL] [Abstract][Full Text] [Related]
28. Immunoregulatory molecules in patients with gestational diabetes mellitus.
Pendeloski KP; Mattar R; Torloni MR; Gomes CP; Alexandre SM; Daher S
Endocrine; 2015 Sep; 50(1):99-109. PubMed ID: 25754913
[TBL] [Abstract][Full Text] [Related]
29. Expression of TIGIT, PD-1 and HLA-DR/CD38 markers on CD8-T cells of children and adolescents infected with HIV and uninfected controls.
Pereira-Manfro WF; Silva GPD; Costa PR; Costa DA; Ferreira BDS; Barreto DM; Frota ACC; Hofer CB; Kallas EG; Milagres LG
Rev Inst Med Trop Sao Paulo; 2023; 65():e14. PubMed ID: 36753067
[TBL] [Abstract][Full Text] [Related]
30. Evidence for involvement of activated CD8+/HLA-DR+ cells in the pathogenesis of neutropenia in patients with B-cell chronic lymphocytic leukaemia.
Katrinakis G; Kyriakou D; Alexandrakis M; Sakellariou D; Foudoulakis A; Eliopoulos GD
Eur J Haematol; 1995 Jul; 55(1):33-41. PubMed ID: 7615048
[TBL] [Abstract][Full Text] [Related]
31. Elevated CD69 expression on naive peripheral blood T-cells in hyperthyroid Graves' disease and autoimmune thyroiditis: discordant effect of methimazole on HLA-DR and CD69.
Gessl A; Waldhäusl W
Clin Immunol Immunopathol; 1998 May; 87(2):168-75. PubMed ID: 9614932
[TBL] [Abstract][Full Text] [Related]
32. A comprehensive assessment of lymphocyte subsets, their prognostic significance, and changes after first-line therapy administration in patients with chronic lymphocytic leukemia.
Vodárek P; Écsiová D; Řezáčová V; Souček O; Šimkovič M; Vokurková D; Belada D; Žák P; Smolej L
Cancer Med; 2023 Mar; 12(6):6956-6970. PubMed ID: 36440594
[TBL] [Abstract][Full Text] [Related]
33. Expansion of T cells expressing low CD4 or CD8 levels in B-cell chronic lymphocytic leukemia: correlation with disease status and neoplastic phenotype.
Dianzani U; Omedè P; Marmont F; DiFranco D; Fusaro A; Bragardo M; Redoglia V; Giaretta F; Mairone L; Boccadoro M
Blood; 1994 Apr; 83(8):2198-205. PubMed ID: 7909242
[TBL] [Abstract][Full Text] [Related]
34. A low blood lymphocyte count is associated with an expansion of activated cytotoxic lymphocytes in patients with B-cell chronic lymphocytic leukaemia.
Martín AP; Martín ER; García-Suárez J; Arriagada FC; del Puerto Hernandez-Fuentes M; Vilaplana JC; Alvarez-Mon Soto M
Eur J Haematol; 1997 Aug; 59(2):89-99. PubMed ID: 9293856
[TBL] [Abstract][Full Text] [Related]
35. Leukemia-associated monoclonal and oligoclonal TCR-BV use in patients with B-cell chronic lymphocytic leukemia.
Rezvany MR; Jeddi-Tehrani M; Wigzell H; Osterborg A; Mellstedt H
Blood; 2003 Feb; 101(3):1063-70. PubMed ID: 12393705
[TBL] [Abstract][Full Text] [Related]
36. Biomarkers of tumor-reactive CD4
Palomero J; Panisello C; Lozano-Rabella M; Tirtakasuma R; Díaz-Gómez J; Grases D; Pasamar H; Arregui L; Dorca Duch E; Guerra Fernández E; Vivancos A; de Andrea CE; Melero I; Ponce J; Vidal A; Piulats JM; Matias-Guiu X; Gros A
J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36581331
[TBL] [Abstract][Full Text] [Related]
37. Immunopathogenesis of dilated cardiomyopathy. Evidence for the role of TH2-type CD4+T lymphocytes and association with myocardial HLA-DR expression.
Kuethe F; Braun RK; Foerster M; Schlenker Y; Sigusch HH; Kroegel C; Figulla HR
J Clin Immunol; 2006 Jan; 26(1):33-9. PubMed ID: 16418801
[TBL] [Abstract][Full Text] [Related]
38. CD8+ T-cells Co-expressing PD-1 and TIGIT Are Highly Frequent in Chronic Lymphocytic Leukemia.
Hajiasghar-Sharbaf R; Asgarian-Omran H; Valadan R; Hossein-Nattaj H; Shekarriz R; Zaboli E; Janbabaei G; Tehrani M
Iran J Allergy Asthma Immunol; 2021 Dec; 20(6):751-763. PubMed ID: 34920658
[TBL] [Abstract][Full Text] [Related]
39. Chronic lymphocytic leukemia-like monoclonal B-cell lymphocytosis exhibits an increased inflammatory signature that is reduced in early-stage chronic lymphocytic leukemia.
Blanco G; Puiggros A; Sherry B; Nonell L; Calvo X; Puigdecanet E; Chiu PY; Kieso Y; Ferrer G; Palacios F; Arnal M; Rodríguez-Rivera M; Gimeno E; Abella E; Rai KR; Abrisqueta P; Bosch F; Calon A; Ferrer A; Chiorazzi N; Espinet B
Exp Hematol; 2021 Mar; 95():68-80. PubMed ID: 33421548
[TBL] [Abstract][Full Text] [Related]
40. Expression of programmed cell death protein 1 and T-cell immunoglobulin- and mucin-domain-containing molecule-3 on peripheral blood CD4+CD8+ double positive T cells in patients with chronic hepatitis C virus infection and in subjects who spontaneously cleared the virus.
Caraballo Cortés K; Osuch S; Perlejewski K; Pawełczyk A; Kaźmierczak J; Janiak M; Jabłońska J; Nazzal K; Stelmaszczyk-Emmel A; Berak H; Bukowska-Ośko I; Paciorek M; Laskus T; Radkowski M
J Viral Hepat; 2019 Aug; 26(8):942-950. PubMed ID: 30972915
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]